Literature DB >> 17037532

Insights from the association of SARS-CoV S-protein with its receptor, ACE2.

Wenhui Li1, Hyeryun Choe, Michael Farzan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037532      PMCID： PMC7123956          DOI： 10.1007/978-0-387-33012-9_36

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  81 in total

1.  Laboratory-acquired severe acute respiratory syndrome.

Authors:  Poh Lian Lim; Asok Kurup; Gowri Gopalakrishna; Kwai Peng Chan; Christopher W Wong; Lee Ching Ng; Su Yun Se-Thoe; Lynette Oon; Xinlai Bai; Lawrence W Stanton; Yijun Ruan; Lance D Miller; Vinsensius B Vega; Lyn James; Peng Lim Ooi; Chew Suok Kai; Sonja J Olsen; Brenda Ang; Yee-Sin Leo
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

2.  A previously undescribed coronavirus associated with respiratory disease in humans.

Authors:  Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

3.  pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.

Authors:  Zhi-Yong Yang; Yue Huang; Lakshmanan Ganesh; Kwanyee Leung; Wing-Pui Kong; Owen Schwartz; Kanta Subbarao; Gary J Nabel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E.

Authors:  Aurelio Bonavia; Bruce D Zelus; David E Wentworth; Pierre J Talbot; Kathryn V Holmes
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

6.  Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.

Authors:  Kanta Subbarao; Josephine McAuliffe; Leatrice Vogel; Gary Fahle; Steven Fischer; Kathleen Tatti; Michelle Packard; Wun-Ju Shieh; Sherif Zaki; Brian Murphy
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

Authors:  Michael J Moore; Tatyana Dorfman; Wenhui Li; Swee Kee Wong; Yanhan Li; Jens H Kuhn; James Coderre; Natalya Vasilieva; Zhongchao Han; Thomas C Greenough; Michael Farzan; Hyeryun Choe
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Coronaviruses in the limelight.

Authors:  Kenneth McIntosh
Journal:  J Infect Dis       Date:  2005-01-14       Impact factor: 5.226

9.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Authors:  Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

10.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

Authors:  N S Zhong; B J Zheng; Y M Li; Z H Xie; K H Chan; P H Li; S Y Tan; Q Chang; J P Xie; X Q Liu; J Xu; D X Li; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321
View more
  11 in total

Review 1.  Cross-species virus transmission and the emergence of new epidemic diseases.

Authors:  Colin R Parrish; Edward C Holmes; David M Morens; Eun-Chung Park; Donald S Burke; Charles H Calisher; Catherine A Laughlin; Linda J Saif; Peter Daszak
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

2.  Evidence supporting a zoonotic origin of human coronavirus strain NL63.

Authors:  Jeremy Huynh; Shimena Li; Boyd Yount; Alexander Smith; Leslie Sturges; John C Olsen; Juliet Nagel; Joshua B Johnson; Sudhakar Agnihothram; J Edward Gates; Matthew B Frieman; Ralph S Baric; Eric F Donaldson
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

3.  Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.

Authors:  Lennart Michel Reinke; Martin Spiegel; Teresa Plegge; Anika Hartleib; Inga Nehlmeier; Stefanie Gierer; Markus Hoffmann; Heike Hofmann-Winkler; Michael Winkler; Stefan Pöhlmann
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

4.  The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity.

Authors:  Lizhou Zhang; Cody B Jackson; Huihui Mou; Amrita Ojha; Erumbi S Rangarajan; Tina Izard; Michael Farzan; Hyeryun Choe
Journal:  bioRxiv       Date:  2020-06-12

5.  Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.

Authors:  Huihui Mou; Brian D Quinlan; Haiyong Peng; Yan Guo; Shoujiao Peng; Lizhou Zhang; Meredith E Davis-Gardner; Matthew R Gardner; Gogce Crynen; Zhi Xiang Voo; Charles C Bailey; Michael D Alpert; Christoph Rader; Hyeryun Choe; Michael Farzan
Journal:  bioRxiv       Date:  2020-06-30

6.  A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.

Authors:  Xiaoning Wang; Chuanxi Yang; Yangyang Sun; Xin Sui; Tong Zhu; Qian Wang; Shuai Wang; Jun Yang; Weijie Yang; Fengying Liu; Minmin Zhang; Yongan Wang; Yuan Luo
Journal:  Environ Int       Date:  2020-12-23       Impact factor: 9.621

7.  An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2.

Authors:  Takuya Tada; Chen Fan; Jennifer S Chen; Ramanjit Kaur; Kenneth A Stapleford; Harry Gristick; Belinda M Dcosta; Craig B Wilen; Crina M Nimigean; Nathaniel R Landau
Journal:  Cell Rep       Date:  2020-12-01       Impact factor: 9.423

Review 8.  Targeting protein-protein interaction interfaces in COVID-19 drug discovery.

Authors:  Chung-Ke Chang; Shan-Meng Lin; Roshan Satange; Shih-Chao Lin; Sin-Cih Sun; Hung-Yi Wu; Kylene Kehn-Hall; Ming-Hon Hou
Journal:  Comput Struct Biotechnol J       Date:  2021-04-15       Impact factor: 7.271

Review 9.  Not just angiotensinases: new roles for the angiotensin-converting enzymes.

Authors:  Daniel W Lambert; Nicola E Clarke; Anthony J Turner
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

10.  SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.

Authors:  Lizhou Zhang; Cody B Jackson; Huihui Mou; Amrita Ojha; Haiyong Peng; Brian D Quinlan; Erumbi S Rangarajan; Andi Pan; Abigail Vanderheiden; Mehul S Suthar; Wenhui Li; Tina Izard; Christoph Rader; Michael Farzan; Hyeryun Choe
Journal:  Nat Commun       Date:  2020-11-26       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.